Wayfair Partners with Perigold and Regeneron’s Streak of Helpful Drugs
Wayfair is an online e-commerce website that sells furniture and home-goods. The digital platform offers over 14 million items from 11,000 global suppliers. Since the pandemic back in March people have spent much more time at home, and with an inability to go out to purchase furniture Wayfair provided a great opportunity. As a result, Wayfair stock saw gains of over 1000% over the past 10 months.
Most recently, Wayfair announced a partnership with Perigold, a luxury furniture company. Moreover, Wayfair became a partner of the Boston While Black network which empowers local African American entrepreneurs.
Regeneron has had a tremendous 2020, with many new drugs. One of its drugs named Eylea, a treatment for retinal diseases, brought in over $4.9 billion in U.S. sales in 2020. But this is only one drug, Regeneron has been working on many new drugs set to drive revenue including an antibody cocktail for treating COVID-19. In clinical studies, the antiviral showed a significant survival benefit for patients with COVID-19 compared to a placebo.
Year to date Regeneron has generated a 12% return for investors, moreover, it’s financials are solid with a valuation at 6.7 times revenue. Comparatively, it is relatively inexpensive when compared to the biopharma industry which has an average of 8.1 times revenue
I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.